Dose-dependent bioavailability of propranolol
- PMID: 3733282
Dose-dependent bioavailability of propranolol
Abstract
The pharmacokinetics of orally administered propranolol in doses of 10, 40, 80 and 160 mg was studied in eight healthy volunteers in a cross-over trial. The analytical method applied made possible a parallel determination of propranolol and of 4-OH propranolol. The dose-dependent kinetics of orally administered propranolol was demonstrated. In our study linear dependence could be established only within a dosage range of 40 mg to 160 mg. Both substances determined in plasma, propranolol as well as 4-OH propranolol, show a tendency toward non-linearity, particularly at the lower dosage range between 10 and 40 mg.
Similar articles
-
Pharmacokinetics of propranolol after single and multiple dosing with sustained release propranolol or propranolol CR (innopran XL) , a new chronotherapeutic formulation.Heart Dis. 2003 May-Jun;5(3):176-81. doi: 10.1097/01.HDX.0000074436.09658.3b. Heart Dis. 2003. PMID: 12783630 Clinical Trial.
-
Plasma concentrations of propranolol and 4-hydroxy-propranolol at steady-state in neurological patients: intersubject and intrasubject correlations with dose.Int J Clin Pharmacol Res. 1984;4(1):19-23. Int J Clin Pharmacol Res. 1984. PMID: 6469429
-
Relationship between plasma propranolol concentration and dose in young, healthy volunteers.Biopharm Drug Dispos. 1986 Mar-Apr;7(2):103-11. doi: 10.1002/bdd.2510070202. Biopharm Drug Dispos. 1986. PMID: 3708118 Clinical Trial.
-
High dose propranolol in the treatment of angina pectoris: relationship of dose to blood levels and hemodynamic consequences.Yale J Biol Med. 1980 May-Jun;53(3):173-9. Yale J Biol Med. 1980. PMID: 6250292 Free PMC article.
-
Stereoselective increase in propranolol bioavailability during chronic dosing in the dog.J Pharmacol Exp Ther. 1983 Nov;227(2):360-4. J Pharmacol Exp Ther. 1983. PMID: 6631718
Cited by
-
Pharmacokinetic and pharmacodynamic comparison of two doses of long acting propranolol (80 and 160 mg) in healthy subjects.Br J Clin Pharmacol. 1989 May;27(5):539-45. doi: 10.1111/j.1365-2125.1989.tb03415.x. Br J Clin Pharmacol. 1989. PMID: 2757878 Free PMC article. Clinical Trial.
-
Propranolol pharmacokinetics in infants treated for Infantile Hemangiomas requiring systemic therapy: Modeling and dosing regimen recommendations.Pharmacol Res Perspect. 2018 Apr 30;6(3):e00399. doi: 10.1002/prp2.399. eCollection 2018 Jun. Pharmacol Res Perspect. 2018. PMID: 29736244 Free PMC article.
-
Effect of exercise on propranolol pharmacokinetics.Eur J Clin Pharmacol. 1990;39(4):391-4. doi: 10.1007/BF00315416. Eur J Clin Pharmacol. 1990. PMID: 2076723